An adult with unilateral Parkinson disease has painful foot dystonia during OFF periods that remains disabling despite medication optimization. You are considering whether the evidence from a randomized, double-blind, placebo-controlled trial supports a targeted injection treatment.
What does this abstract support for painful foot dystonia in Parkinson disease refractory to medication optimization?